Barclays raised its price target on
Tesla Motors (NASDAQ:
TSLA) to $210.00 (from $165.00) while maintaining a Underweight rating.
Analyst Brian Johnson remains negative on the company noting that attempts to ascertain the right valuation for Tesla "seems futile" and this morning decided to take a shot at it. The analyst comments "The market clearly disagrees with our conservative valuation of Tesla, and we are still refining our “ROT (return on tweet)” analysis as the ultimate valuation tool. Yet to understand our disconnect w/ the market, we re-examine our scenario-based valuation approach. What’s clear is that the largest driver of Tesla valuation is hopes of dream / ‘blue pill’ scenarios."
Johnson says it is not a stretch to see how Tesla could be worth $600 per share and believes wholeheartedly that the stock is fundamentally overvalued which would not matter to bulls that get excited about the future opportunities for the company "(energy, mobility, hyperloop, Neuralink...cars on Mars?)."
FY 2017 EPS estimate falls from ($7.84) to ($8.33) and FY 2018 EPS estimate falls from ($5.33) to ($9.37).